KR20090050056A - 헤마글루티닌 폴리펩티드 및 시약 그리고 방법 - Google Patents

헤마글루티닌 폴리펩티드 및 시약 그리고 방법 Download PDF

Info

Publication number
KR20090050056A
KR20090050056A KR1020097003179A KR20097003179A KR20090050056A KR 20090050056 A KR20090050056 A KR 20090050056A KR 1020097003179 A KR1020097003179 A KR 1020097003179A KR 20097003179 A KR20097003179 A KR 20097003179A KR 20090050056 A KR20090050056 A KR 20090050056A
Authority
KR
South Korea
Prior art keywords
ser
asn
gly
leu
ile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020097003179A
Other languages
English (en)
Korean (ko)
Inventor
람 새시세카란
카틱 비스와나단
아르티 찬드라세카란
라훌 라만
아라빈드 시린바산
에스. 라구람
비스와나단 새시세카란
Original Assignee
메사츄세츠 인스티튜트 어브 테크놀로지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메사츄세츠 인스티튜트 어브 테크놀로지 filed Critical 메사츄세츠 인스티튜트 어브 테크놀로지
Publication of KR20090050056A publication Critical patent/KR20090050056A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
KR1020097003179A 2006-08-14 2007-08-14 헤마글루티닌 폴리펩티드 및 시약 그리고 방법 Ceased KR20090050056A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83786806P 2006-08-14 2006-08-14
US83786906P 2006-08-14 2006-08-14
US60/837,869 2006-08-14
US60/837,868 2006-08-14

Publications (1)

Publication Number Publication Date
KR20090050056A true KR20090050056A (ko) 2009-05-19

Family

ID=39082721

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097003179A Ceased KR20090050056A (ko) 2006-08-14 2007-08-14 헤마글루티닌 폴리펩티드 및 시약 그리고 방법

Country Status (8)

Country Link
US (3) US20080241918A1 (enExample)
EP (2) EP2052340A4 (enExample)
JP (2) JP2010501074A (enExample)
KR (1) KR20090050056A (enExample)
AU (2) AU2007284496A1 (enExample)
CA (2) CA2660128A1 (enExample)
IL (1) IL196738A0 (enExample)
WO (2) WO2008021415A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101425404B1 (ko) * 2009-07-17 2014-08-01 한림대학교 산학협력단 리포좀에 포집된 올리고뉴클레오타이드 및 에피토프를 포함하는 면역증강용 조성물

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ573079A (en) * 2006-05-30 2012-06-29 Samuel Winston Bogoch Replikin peptides and uses thereof
WO2008140557A2 (en) * 2006-10-24 2008-11-20 Samuel Bogoch A method of predicting influenza outbreaks
EP2126140A4 (en) * 2007-01-18 2012-03-28 Samuel Bogoch METHOD FOR DETERMINING THE MORTALITY OF PATHOGENS AND MALIGNOMAS WITH REPLICINE TIPS
MX2009013091A (es) * 2007-05-30 2010-07-30 Bogoch Samuel Peptidos de repliquina sinteticos contra infeccion patogenica de invertebrados en acuicultura.
WO2009089119A2 (en) * 2008-01-03 2009-07-16 Massachusetts Institute Of Technology Decoy influenza therapies
WO2009089121A2 (en) * 2008-01-03 2009-07-16 Massachusetts Institute Of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
US20090269367A1 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
US20100144589A1 (en) * 2008-08-08 2010-06-10 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) * 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
JP5396111B2 (ja) * 2009-03-12 2014-01-22 学校法人慶應義塾 インフルエンザ治療／予防薬
EP2411049B1 (en) 2009-03-27 2020-01-15 Academia Sinica Methods and compositions for immunization against virus
CA2759325A1 (en) * 2009-04-23 2010-10-28 Samuel Bogoch Replikin-sequences for preventing/treating influenza and determining infectivity/lethality
JP5886194B2 (ja) * 2009-07-02 2016-03-16 マサチューセッツ インスティテュート オブ テクノロジー インフルエンザ感染の診断および／または処置のための組成物および方法
US20110091493A1 (en) * 2009-10-16 2011-04-21 Northwestern University Vaccine compositions and uses thereof
JP6210685B2 (ja) 2010-01-27 2017-10-11 マサチューセッツ インスティテュート オブ テクノロジー 標的化された広域スペクトルのインフルエンザ中和のための操作されたポリペプチド剤
JP2013541528A (ja) * 2010-09-21 2013-11-14 マサチューセッツ インスティテュート オブ テクノロジー ヒト適応ｈａポリペプチド、ワクチン、およびインフルエンザの処置
SG10201709806VA (en) * 2010-10-04 2017-12-28 Massachusetts Inst Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法
AU2011344126B2 (en) 2010-12-13 2016-11-10 The University Of Utah Research Foundation Vaccine antigens that direct immunity to conserved epitopes
AU2012283914A1 (en) 2011-07-20 2014-01-30 Bogoch, Elanore S. Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
MX359071B (es) 2012-02-13 2018-09-13 Univ Pittsburgh Commonwealth Sys Higher Education Antígenos ampliamente reactivos computacionalmente optimizados para influenza h5n1 humana y aviar.
SG11201405317QA (en) * 2012-02-29 2014-09-26 Agency Science Tech & Res Modulating the interaction between zo-2/tjp2 and a snail zinc finger transcription factor family member
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
US9683030B2 (en) 2012-05-10 2017-06-20 Massachusetts Institute Of Technology Agents for influenza neutralization
BR112015001100A2 (pt) 2012-07-19 2018-03-27 Toray Industries, Inc. método de detecção de câncer
US20140286981A1 (en) * 2013-03-14 2014-09-25 Wisconsin Alumni Research Foundation Broadly reactive mosaic peptide for influenza vaccine
WO2014197723A2 (en) 2013-06-05 2014-12-11 Massachusetts Institute Of Technology Human adaptation of h7 ha
EP3916390A1 (en) * 2014-06-04 2021-12-01 Indevr, Inc. Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins
KR102688257B1 (ko) * 2015-08-20 2024-07-26 시러스 로직 인터내셔널 세미컨덕터 리미티드 피드백 적응적 잡음 소거(anc) 제어기 및 고정 응답 필터에 의해 부분적으로 제공되는 피드백 응답을 갖는 방법
WO2017083627A1 (en) 2015-11-13 2017-05-18 Visterra, Inc. Compositions and methods for treating and preventing influenza
CN109195629A (zh) 2016-02-24 2019-01-11 威特拉公司 流行性感冒抗体分子制剂
SG11202003793WA (en) 2017-10-30 2020-05-28 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CA3132521A1 (en) 2019-03-25 2020-10-01 Visterra, Inc. Compositions and methods for treating and preventing influenza
WO2021119467A1 (en) 2019-12-11 2021-06-17 Visterra, Inc. Compositions and methods for treating and preventing influenza

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) * 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4270537A (en) * 1979-11-19 1981-06-02 Romaine Richard A Automatic hypodermic syringe
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4596556A (en) * 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
US4886499A (en) * 1986-12-18 1989-12-12 Hoffmann-La Roche Inc. Portable injection appliance
GB8704027D0 (en) * 1987-02-20 1987-03-25 Owen Mumford Ltd Syringe needle combination
US4941880A (en) * 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
US4790824A (en) * 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4940460A (en) * 1987-06-19 1990-07-10 Bioject, Inc. Patient-fillable and non-invasive hypodermic injection device assembly
US5339163A (en) * 1988-03-16 1994-08-16 Canon Kabushiki Kaisha Automatic exposure control device using plural image plane detection areas
FR2638359A1 (fr) * 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
US5064413A (en) * 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) * 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5190521A (en) * 1990-08-22 1993-03-02 Tecnol Medical Products, Inc. Apparatus and method for raising a skin wheal and anesthetizing skin
US5527288A (en) * 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
JPH06247995A (ja) * 1991-06-24 1994-09-06 Asahi Chem Ind Co Ltd 新規なシアリル（α２−６）ラクトテトラオシルセラミド
GB9118204D0 (en) * 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
SE9102652D0 (sv) * 1991-09-13 1991-09-13 Kabi Pharmacia Ab Injection needle arrangement
US5328483A (en) * 1992-02-27 1994-07-12 Jacoby Richard M Intradermal injection device with medication and needle guard
US5383851A (en) * 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
US5569189A (en) * 1992-09-28 1996-10-29 Equidyne Systems, Inc. hypodermic jet injector
US5334144A (en) * 1992-10-30 1994-08-02 Becton, Dickinson And Company Single use disposable needleless injector
WO1995024176A1 (en) * 1994-03-07 1995-09-14 Bioject, Inc. Ampule filling device
US5466220A (en) * 1994-03-08 1995-11-14 Bioject, Inc. Drug vial mixing and transfer device
US5599302A (en) * 1995-01-09 1997-02-04 Medi-Ject Corporation Medical injection system and method, gas spring thereof and launching device using gas spring
US5893397A (en) * 1996-01-12 1999-04-13 Bioject Inc. Medication vial/syringe liquid-transfer apparatus
US5993412A (en) * 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
WO2000059932A1 (fr) * 1999-03-31 2000-10-12 Otsuka Pharmaceutical Co., Ltd. Peptides se liant a l'hemagglutinine du virus de la grippe
CN1639199A (zh) * 2002-03-04 2005-07-13 独立行政法人科学技术振兴机构 新型支链状唾液糖分子与使用该糖分子的抗病毒剂
EP1573047B1 (en) * 2002-08-20 2013-11-13 OpSaniTx LLC Lectin compositions and methods for modulating an immune response to an antigen
US20050221337A1 (en) * 2003-10-02 2005-10-06 Massachusetts Institute Of Technology Microarrays and microspheres comprising oligosaccharides, complex carbohydrates or glycoproteins
JP2007527539A (ja) * 2004-03-05 2007-09-27 ザ スクリプス リサーチ インスティテュート ハイスループットグリカンマイクロアレイ
AU2005303817B8 (en) * 2004-11-11 2010-09-30 Abbott Biologicals B.V. Defective influenza virus particles
US7959929B2 (en) * 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
WO2007123951A2 (en) * 2006-04-18 2007-11-01 The Regents Of The University Of Michigan Methods and compositions for screening of glycan structures
WO2008153615A2 (en) * 2007-03-07 2008-12-18 Ada Technologies, Inc. Preparing carbohydrate microarrays and conjugated nanoparticles
US20110257032A1 (en) * 2010-04-16 2011-10-20 Massachusetts Institute Of Technology Modular glycan arrays

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101425404B1 (ko) * 2009-07-17 2014-08-01 한림대학교 산학협력단 리포좀에 포집된 올리고뉴클레오타이드 및 에피토프를 포함하는 면역증강용 조성물

Also Published As

Publication number Publication date
IL196738A0 (en) 2011-08-01
WO2008073161A3 (en) 2009-05-22
AU2007332987B2 (en) 2013-01-10
JP2010501074A (ja) 2010-01-14
CA2660128A1 (en) 2008-02-21
WO2008073161A2 (en) 2008-06-19
WO2008073161A9 (en) 2008-07-31
JP2010500880A (ja) 2010-01-14
WO2008021415A2 (en) 2008-02-21
CA2660038A1 (en) 2008-06-19
EP2049569A4 (en) 2010-11-24
US20100061990A1 (en) 2010-03-11
US20080241918A1 (en) 2008-10-02
AU2007332987A1 (en) 2008-06-19
WO2008021415A3 (en) 2008-11-20
EP2052340A2 (en) 2009-04-29
US20100125043A1 (en) 2010-05-20
AU2007284496A1 (en) 2008-02-21
EP2052340A4 (en) 2010-11-17
WO2008021415A9 (en) 2008-07-10
EP2049569A2 (en) 2009-04-22

Similar Documents

Publication Publication Date Title
KR20090050056A (ko) 헤마글루티닌 폴리펩티드 및 시약 그리고 방법
JP6143902B2 (ja) 血球凝集素ポリペプチド、ならびにそれに関連する試薬および方法
JP2010500880A5 (enExample)
US20090081193A1 (en) Hemagglutinin polypeptides, and reagents and methods relating thereto
EP2448596B1 (en) Compositions and methods for diagnosing and/or treating influenza infection
US20090269342A1 (en) Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
AU2011305371B2 (en) Human-adapted HA polypeptides, vaccines, and influenza treatment
US20140335504A1 (en) Human adaptation of h5 influenza
EP2238146A2 (en) Hemagglutinin polypeptides, and reagents and methods relating thereto
CN101553502A (zh) 血球凝集素多肽和其相关试剂和方法
HK1218923B (en) Human adaptation of h5 influenza

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20090217

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120814

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20131127

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20140828

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20131127

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I